Abstract

sBackgroundEven though, the disclosure of HIV sero- status to sexual partners, friends or relatives is the main tool for prevention and care strategies, most of the HIV/AIDS patients do not inform their close friends. The most common reasons for not disclosure of their status to the community were majorly fear of social rejection and discriminations. Therefore, this study assessed the HIV positive sero-status disclosure and its determinants among People Living with HIV /AIDS (PLWH/A) followed by the Antiretroviral therapy (ART) Clinic in Jimma University Specialized Hospital, Southwest Ethiopia.MethodsA facility based cross-sectional study design was used among 351 ART patients that selected by systematic random sampling from ART clinic of Jimma University Specialized Hospital in March-2014. Data were collected through interviewer-administered questionnaires and analyzed using SPSS version 20.0 software. In a descriptive analysis frequency, mean and percentage were calculated. Bivariate and multivariate analyses were used to identify associated factors and the association between the explanatory and dependent variables was estimated.ResultsOnly 37.6% (n = 132) were revealed their HIV positive status to anyone. Disclosure was done towards the sexual partners (88.6%), close family (72.7%) and a larger population (18.2%). Age ≤ 39 years (AOR = 0.014 [95%, CI = 0.005, 0.037]),Male sex (AOR = 3.039, [95% CI = 1.164, 7.935]), WHO stage III – IV at ART start(AOR = 2.766, [95%, CI = 1.321, 5.791]), presence of comorbidity (AOR = 2.500, [95%, CI = 1.483, 4.214]), having any clinical symptoms for HIV(AOR = 2.98, [95%, CI = 1.724, 5.152]),Low physical domain related quality of life (AOR = 3.83, [95%, CI = 2.008, 7.315]) and high social domain related quality of life (AOR = 0.053, [95%, CI = 0.022, 0.125]) were statistically significant association with their HIV sero-status disclosure.ConclusionsFindings of this study indicated, the disclosure of HIV status is very low. Discloser is more likely when the patient is older, male, and has a higher level of education. Clinical determinants for disclosure was the WHO stage III-IV, treatment duration of ≥2 years, comorbidity, presence of clinical symptoms for HIV, low physical domain related quality of life, low social domain related quality of life and low overall quality of life.

Highlights

  • Even though, the disclosure of human immune deficiency virus (HIV) sero- status to sexual partners, friends or relatives is the main tool for prevention and care strategies, most of the HIV/Acquired Immunodeficiency Syndrome (AIDS) patients do not inform their close friends

  • Positive sero - status disclosure and its determinants among People Living with HIV /AIDS following Antiretroviral therapy (ART) Clinic in Jimma University Specialized Hospital, Southwest Ethiopia

  • Discussions This study had assessed the HIV positive sero-status disclosure and its determinants among People Living with HIV /AIDS following ART Clinic in Jimma University Specialized Hospital, Southwest Ethiopia

Read more

Summary

Introduction

The disclosure of HIV sero- status to sexual partners, friends or relatives is the main tool for prevention and care strategies, most of the HIV/AIDS patients do not inform their close friends. This study assessed the HIV positive sero-status disclosure and its determinants among People Living with HIV /AIDS (PLWH/A) followed by the Antiretroviral therapy (ART) Clinic in Jimma University Specialized Hospital, Southwest Ethiopia. HIV is referred to (Human Immunodeficiency Infection) which is the most dangerous virus which is the major cause of AIDS in human life. It continued to spread worldwide and one of serious health challenges. This was high of 33.3 million in 2010 These increments in a number of patients were resulted because of continuing new infections, people living longer with HIV, and general population growth. 1.8 million Children living with HIV, 110,000 AIDS-related deaths, and 150,000 new infections among children in 2015 [3] An estimated 32.1 million of adults aged 15– 49 years worldwide are living with HIV [2]. 1.8 million Children living with HIV, 110,000 AIDS-related deaths, and 150,000 new infections among children in 2015 [3]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call